News & Updates

Show Multimedia Only
Apremilast safe, effective in mild-to-moderate psoriasis

Apremilast safe, effective in mild-to-moderate psoriasis

22 Jan 2022
Metabolic syndrome linked to greater COVID-19 severity

Metabolic syndrome linked to greater COVID-19 severity

21 Jan 2022 byRoshini Claire Anthony

Individuals with metabolic syndrome who are hospitalized for COVID-19 may have a greater risk for more severe COVID-19 disease, including an elevated risk of in-hospital mortality, acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission, a recent prospective study showed.

Metabolic syndrome linked to greater COVID-19 severity

21 Jan 2022
Upper extremity DVT common in COVID-19 despite proper prophylaxis

Upper extremity DVT common in COVID-19 despite proper prophylaxis

21 Jan 2022

About 10 percent of patients with the coronavirus disease 2019 (COVID-19) will suffer from upper extremity deep vein thrombosis despite adequate prophylaxis, a recent study has found.

Upper extremity DVT common in COVID-19 despite proper prophylaxis

21 Jan 2022
Osteoporosis drug holidays tied to small rise in hip fracture risk

Osteoporosis drug holidays tied to small rise in hip fracture risk

21 Jan 2022

The risk for hip fracture slightly increases following osteoporosis drug holidays after long-term therapy with risedronate compared with alendronate, a study has found, adding that future research must examine how best to lessen such risk.

Osteoporosis drug holidays tied to small rise in hip fracture risk

21 Jan 2022